Krognes Steve E. 4

What Happened

• Steve E. Krognes, a director of Guardant Health (GH), had 155 restricted stock units (RSUs) convert into 155 common shares on March 31, 2026. The reported per-share price is $0.00, indicating a vesting/conversion of previously granted RSUs rather than a purchase or sale of shares.

Key Details

• Transaction date: 2026-03-31; Form 4 filed 2026-04-01 (timely filing).
• Reported entries: exercise/conversion of a derivative (transaction code M) showing 155 shares acquired at $0.00 and a corresponding derivative disposition of 155 shares at $0.00.
• Shares owned after the transaction: not specified in the provided filing details.
• Footnotes: F1 — These shares represent an RSU award granted 8/9/2022 that vests over 4 years (25% vested 6/30/2023; remaining 75% vests in equal monthly installments over the next three years). F2 — Not applicable for RSUs.
• No indication in this filing that shares were sold immediately (no open-market sale reported).

Context

• This was an administrative conversion of vested RSUs into common stock (routine compensation vesting), not an open-market purchase or sale. The $0.00 per-share amount reflects that the shares were issued upon vesting of prior awards rather than bought with cash. Such vesting events are common for directors and executives and do not, by themselves, indicate a buy/sell signal.